118 related articles for article (PubMed ID: 1269196)
1. Sodium salicylamide: relative bioavailability and subjective effects.
Fleckenstein L; Mundy GR; Horovitz RA; Mazzullo JM
Clin Pharmacol Ther; 1976 Apr; 19(4):451-8. PubMed ID: 1269196
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
[TBL] [Abstract][Full Text] [Related]
3. Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration.
Wein S; Cermak R; Wolffram S; Langguth P
Xenobiotica; 2012 May; 42(5):477-82. PubMed ID: 22188411
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration.
Waschek JA; Fielding RM; Pond SM; Rubin GM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1985 Aug; 234(2):431-4. PubMed ID: 4020679
[TBL] [Abstract][Full Text] [Related]
5. First-pass elimination of salicylamide in man following oral and rectal administration.
de Boer AG; Breimer DD; Gubbens-Stibbe JM; Bosma A
Biopharm Drug Dispos; 1983; 4(4):321-30. PubMed ID: 6689276
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of the hypnotic effect of salicylamide in rats.
Morris ME; Levy G
J Pharm Sci; 1985 Jun; 74(6):599-602. PubMed ID: 4020644
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of aspirin and salicylamide following oral co-administration in human volunteers.
Abdel-Rahman MS; Reddi AS; Curro FA; Turkall RM; Kadry AM; Hansrote JA
Can J Physiol Pharmacol; 1991 Oct; 69(10):1436-42. PubMed ID: 1777842
[TBL] [Abstract][Full Text] [Related]
8. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
Pond SM; Waschek JA; Mahacha V; Fielding RM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1988 Apr; 245(1):291-3. PubMed ID: 3361447
[TBL] [Abstract][Full Text] [Related]
9. 3-Hydroxylation of salicylamide in mice.
Howell SR; Kotkoskie LA; Dills RL; Klaassen CD
J Pharm Sci; 1988 Apr; 77(4):309-13. PubMed ID: 3379587
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic method for the quantitation of salicylamide and its metabolites in biological fluids.
Xu X; Pang KS
J Chromatogr; 1987 Sep; 420(2):313-27. PubMed ID: 3693503
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral pretreatment with indomethacin on the intestinal first-pass metabolism of salicylamide in rabbits.
Nakamura J; Seki N; Sasaki H; Shibasaki J
J Pharmacobiodyn; 1988 Sep; 11(9):620-4. PubMed ID: 3216283
[TBL] [Abstract][Full Text] [Related]
12. Salicylamide pharmacokinetics in healthy males: dietary effect.
Morad AR
Biopharm Drug Dispos; 1982; 3(2):175-83. PubMed ID: 7104464
[TBL] [Abstract][Full Text] [Related]
13. An assessment of salicylic acid-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):815-8. PubMed ID: 1611698
[TBL] [Abstract][Full Text] [Related]
14. An assessment of indomethacin-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1261-5. PubMed ID: 1394644
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the first-pass metabolism of ethenzamide and salicylamide in rats.
Shibasaki J; Konishi R; Takemura M; Fukushima E; Nakamura J; Sasaki H
J Pharmacobiodyn; 1984 Nov; 7(11):804-10. PubMed ID: 6530645
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
Pang KS; Barker F; Schwab AJ; Goresky CA
J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
[TBL] [Abstract][Full Text] [Related]
17. An assessment of mucosal damage in vivo: effect of oral pretreatment with 5-fluorouracil on the intestinal first-pass metabolism of salicylamide in rabbits.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1011-5. PubMed ID: 1525929
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of salicylamide in the intestinal wall of dogs and rabbits.
Podder SK; Nakashima M; Nakamura T; Sasaki H; Nakamura J; Shibasaki J
J Pharmacobiodyn; 1986 Nov; 9(11):917-22. PubMed ID: 3559882
[TBL] [Abstract][Full Text] [Related]
19. Extrahepatic extraction of salicylamide in dogs.
Fielding RM; Waschek JA; Effeney DJ; Pogany AC; Pond SM; Tozer TN
J Pharmacol Exp Ther; 1986 Jan; 236(1):97-102. PubMed ID: 3941404
[TBL] [Abstract][Full Text] [Related]
20. Difference in hepatic uptake kinetics of aspirin and salicylamide in rats.
Iwamoto K; Furune Y; Watanabe J
Biochem Pharmacol; 1984 Oct; 33(19):3089-95. PubMed ID: 6487359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
